John Panagides
Impact in
- Psychiatry and Mental health top 2%
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment
- Pharmacology top 5%
- Treatment of Major Depression
- Pharmacogenetics and Drug Metabolism
- Inflammatory mediators and NSAID effects
Papers in
-
- Schizophrenia research and treatment 23
- Bipolar Disorder and Treatment 16
- Pharmacology 12
- Inflammatory mediators and NSAID effects 6
- Treatment of Major Depression 6
- Co-authors
- Jun Zhao (10 shared papers)Larry D Alphs (18 shared papers)Roger S. McIntyre (11 shared papers)Thomas A. Macek (10 shared papers)Armin Szegedi (10 shared papers)John Michael Kane (4 shared papers)Mary Mackle (5 shared papers)Ward T. Smith (1 shared paper)
- Journals
- European Neuropsychopharmacology (8 papers)Schizophrenia Research (6 papers)Journal of Affective Disorders (4 papers)Pharmacopsychiatry (3 papers)European Psychiatry (3 papers)
- Partner nations
- United StatesNetherlandsCanada
In The Last Decade
John Panagides
58 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 72
- Psychiatry and Mental health 968
- Pharmacology 234
- Pharmacology 62
- Rheumatology 48
- Cellular and Molecular Neuroscience 50
Countries citing papers authored by John Panagides
This map shows the geographic impact of John Panagides's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Panagides with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Panagides more than expected).
Fields of papers citing papers by John Panagides
This network shows the impact of papers produced by John Panagides. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Panagides. The network helps show where John Panagides may publish in the future.
Co-authors
The 25 scholars most cited alongside John Panagides, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 138 | |
| 2 | 2010 | 116 | |
| 3 | 2010 | 103 | |
| 4 | Mirtazapine vs. amitriptyline vs. placebo in the treatment of major depressive disorder. | 1990 | 98 |
| 5 | 2009 | 79 | |
| 6 | 2010 | 74 | |
| 7 | 2011 | 71 | |
| 8 | 2010 | 70 | |
| 9 | 2011 | 62 | |
| 10 | 2011 | 58 | |
| 11 | 2011 | 53 | |
| 12 | 2010 | 49 | |
| 13 | Development of new antidepressants. | 1997 | 40 |
| 14 | 1997 | 35 | |
| 15 | Etodolac compared with aspirin: an endoscopic study of the gastrointestinal tracts of normal volunteers. | 1986 | 34 |
| 16 | The 4-Item Negative Symptom Assessment (NSA-4) Instrument: A Simple Tool for Evaluating Negative Symptoms in Schizophrenia Following Brief Training. | 2010 | 28 |
| 17 | 1980 | 27 | |
| 18 | 1988 | 25 | |
| 19 | 2017 | 25 | |
| 20 | 2012 | 24 |
About John Panagides
John Panagides is a scholar working on Psychiatry and Mental health, Pharmacology, Cell Biology, Rheumatology and Pharmacology, having authored 60 papers that have together received 1.5k indexed citations. Recurring topics across this work include Schizophrenia research and treatment (23 papers), Bipolar Disorder and Treatment (16 papers), Inflammatory mediators and NSAID effects (6 papers), Treatment of Major Depression (6 papers), Nematode management and characterization studies (2 papers), Protease and Inhibitor Mechanisms (2 papers), Osteoarthritis Treatment and Mechanisms (2 papers) and Proteoglycans and glycosaminoglycans research (2 papers). The work is most often cited by research in Psychiatry and Mental health (968 citations), Pharmacology (234 citations), Pharmacology (62 citations), Rheumatology (48 citations) and Cellular and Molecular Neuroscience (50 citations). John Panagides has collaborated with scholars based in United States, Netherlands and Canada. Frequent co-authors include Jun Zhao, Larry D Alphs, Roger S. McIntyre, Thomas A. Macek, Armin Szegedi, John Michael Kane, Mary Mackle, Ward T. Smith, Vincent Glaudin and Dieter Naber. Their work appears in journals such as European Neuropsychopharmacology, Schizophrenia Research, Journal of Affective Disorders, Pharmacopsychiatry and European Psychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.